Search This Blog

Sunday, November 8, 2015

Patients Show Significant Improvement in Signs and Symptoms of Psoriatic Arthritis, Less Progression of Structural Joint Damage When Treated with Ixekizumab for 24 Weeks (NYSE:LLY)

Patients Show Significant Improvement in Signs and Symptoms of Psoriatic Arthritis, Less Progression of Structural Joint Damage When Treated with Ixekizumab for 24 Weeks (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.